TEVA Other Income/Expenses (Net)

Teva Pharmaceutical Industries Limited American Depositary Shares · Other Income/Expenses (Net)

TEVA logo

TEVA Other Income/Expenses (Net)

Latest reported-$1.26B
TEVA Other Income/Expenses (Net) ($1.00M → -$1.26B)
High-resolution chart · PNG

TEVA other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-919,000,000
-980,000,000
-1,055,000,000
-945,000,000
-1,049,000,000
-359,000,000
-280,000,000
-959,000,000
-895,000,000
-1,330,000,000
-1,000,000,000
-313,000,000
-399,000,000
-386,000,000
-153,000,000
-225,000,000
-202,000,000
-318,000,000
-42,000,000
-95,000,000
-3,900,000
-588,268,267
-5,000,000
-24,600,000
-18,930,000
-36,543,000
-36,878,000
-45,282,000
-33,597,000
-35,000,000
-7,500,000
-4,900,000
-3,000,000
-2,100,000
-15,100,000
-9,800,000
-19,100,000
-3,400,000
2,700,000
1,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.